Semin Musculoskelet Radiol 2024; 28(04): 505-510
DOI: 10.1055/s-0044-1782205
Review Article

Skeletal Manifestations of Gaucher's Disease: A Case Report and Literature Review

Rahma Nour Eldin Saad Mohamed
1   Department of Diagnostic and Interventional Radiology, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt
,
Walid A. Elnahal
2   Department of Trauma and Orthopaedics, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt
,
Cleofina Furtado
3   Department of Diagnostic and Interventional Radiology, University Hospitals of North Midlands NHS Trust, Stoke on Trent, United Kingdom
,
1   Department of Diagnostic and Interventional Radiology, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt
,
Nagui Abdel-Wahab
1   Department of Diagnostic and Interventional Radiology, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt
› Author Affiliations

Abstract

Gaucher's disease (GD) is a lysosomal storage disorder characterized by the storage of glucosylceramide in macrophages (“Gaucher cells”), mainly in the reticuloendothelial system. GD type 1 (GD1) is the most common phenotype that usually manifests with hepatosplenomegaly, cytopenias, and bone involvement. Skeletal manifestations are the most debilitating characteristic and result in significant morbidities. We describe a case of GD1, first presented by a nontraumatic bone fracture. The case presentation highlights the importance of considering GD among the differential diagnosis of nontraumatic fractures, avascular necrosis, and infarcts of the bones. Early diagnosis and treatment improve the course of disease and avoid irreversible sequelae.



Publication History

Article published online:
29 July 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Castillon G, Chang SC, Moride Y. Global incidence and prevalence of Gaucher disease: a targeted literature review. J Clin Med 2022; 12 (01) 85
  • 2 Pastores GM, Hughes DA. Gaucher disease. In: Adam MP, Mirzaa GM, Pagon RA. et al., eds. GeneReviews. Seattle: University of Washington; 2023. . Available at: http://www.ncbi.nlm.nih.gov/books/NBK1269/. Accessed February 12, 2024
  • 3 Abdelazeem H, Abdelazeem A, Al-Dars A, Hegazy M, Abdellatif N. Triple attack technique for non-union of femoral neck fractures. Int Orthop 2016; 40 (04) 807-812
  • 4 Grigoris P, Grecula MJ, Amstutz HC. Hip arthroplasty for femoral head osteonecrosis in Gaucher's disease. Hip Int 1995; 5 (01) 25-30
  • 5 Donaldson J, Khan WS, Tailor H, Hughes DA, Mehta AB, Maruthainar N. Gaucher disease: outcome following total hip replacements and effect of enzyme replacement therapy in a cohort of UK patients. Hip Int 2011; 21 (06) 665-671
  • 6 Nguyen Y, Stirnemann J, Belmatoug N. Gaucher disease: a review. [in French]. Rev Med Interne 2019; 40 (05) 313-322
  • 7 Rosenbloom BE, Weinreb NJ, Zimran A, Kacena KA, Charrow J, Ward E. Gaucher disease and cancer incidence: a study from the Gaucher Registry. Blood 2005; 105 (12) 4569-4572
  • 8 Dandana A, Ben Khelifa S, Chahed H, Miled A, Ferchichi S. Gaucher disease: clinical, biological and therapeutic aspects. Pathobiology 2016; 83 (01) 13-23
  • 9 Hughes D, Mikosch P, Belmatoug N. et al. Gaucher disease in bone: from pathophysiology to practice. J Bone Miner Res 2019; 34 (06) 996-1013
  • 10 Wenstrup RJ, Roca-Espiau M, Weinreb NJ, Bembi B. Skeletal aspects of Gaucher disease: a review. Br J Radiol 2002; 75 (Suppl. 01) A2-A12
  • 11 Lutsky KF, Tejwani NC. Orthopaedic manifestations of Gaucher disease. Bull NYU Hosp Jt Dis 2007; 65 (01) 37-42
  • 12 Gigis I, Pitsilos C, Samoladas E. et al. Gaucher disease: an unusual cause of knee pain. J Am Acad Orthop Surg Glob Res Rev 2022; 6 (10) e21
  • 13 Gragnaniello V, Burlina AP, Manara R. et al. Bone disease in early detected Gaucher type I disease: a case report. JIMD Rep 2022; 63 (05) 414-419
  • 14 Weinreb NJ, Goker-Alpan O, Kishnani PS. et al. The diagnosis and management of Gaucher disease in pediatric patients: where do we go from here?. Mol Genet Metab 2022; 136 (01) 4-21
  • 15 Simpson WL, Hermann G, Balwani M. Imaging of Gaucher disease. World J Radiol 2014; 6 (09) 657-668
  • 16 Degnan AJ, Ho-Fung VM, Ahrens-Nicklas RC. et al. Imaging of non-neuronopathic Gaucher disease: recent advances in quantitative imaging and comprehensive assessment of disease involvement. Insights Imaging 2019; 10 (01) 70
  • 17 Maas M, Hollak CEM, Akkerman EM, Aerts JMFG, Stoker J, Den Heeten GJ. Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter. AJR Am J Roentgenol 2002; 179 (04) 961-965
  • 18 Mariani G, Filocamo M, Giona F. et al. Severity of bone marrow involvement in patients with Gaucher's disease evaluated by scintigraphy with 99mTc-sestamibi. J Nucl Med 2003; 44 (08) 1253-1262
  • 19 Marcucci G, Zimran A, Bembi B. et al. Gaucher disease and bone manifestations. Calcif Tissue Int 2014; 95 (06) 477-494
  • 20 Kasapkara ÇS, Olgaç A, Okur İ, Ezgu FS, Tümer L. The evaluation of skeletal manifestations in patients with Gaucher disease. JPR 2021; 8 (03) 257-261